Tag Archive for: renal calculi

Kidney Stones: Understanding the Different Types of Renal Calculi and Their Treatment

Kidney stones, medically known as renal calculi or nephrolithiasis, are solid crystalline deposits that develop within the kidneys. Although we tend to talk about “a kidney stone” as if all stones are the same, there are several distinctly different types.

Knowing the composition of a kidney stone matters. Different stones have different causes, appearances, recurrence risks and, importantly, different strategies for prevention and treatment.

Modern management therefore involves more than simply removing the stone. The aim is to answer three questions:

What is the stone? Why did it form? And how can we prevent the next one?


What Are Kidney Stones Made Of?

The major types of urinary stones are:

  1. Calcium oxalate stones
  2. Calcium phosphate stones
  3. Uric acid stones
  4. Struvite or infection stones
  5. Cystine stones
  6. Rare metabolic and medication-related stones

Stones are not always chemically pure. Many contain a mixture of different crystalline components.

The European Association of Urology recommends reliable stone analysis and a basic metabolic evaluation in stone-forming patients, with more detailed metabolic investigation particularly important in patients at high risk of recurrence.


1. Calcium Oxalate Stones

The most common kidney stone

Calcium oxalate stones are the most frequently encountered urinary calculi.

They may consist predominantly of:

  • Calcium oxalate monohydrate, known as whewellite
  • Calcium oxalate dihydrate, known as weddellite

Calcium oxalate monohydrate stones can be particularly hard and resistant to fragmentation with shockwave lithotripsy.

Why do calcium oxalate stones form?

Contributing factors may include:

  • Low urine volume or dehydration
  • Excess urinary calcium
  • Excess urinary oxalate
  • Low urinary citrate
  • High dietary sodium intake
  • Excessive animal protein intake
  • Certain bowel diseases or previous intestinal surgery
  • Genetic predisposition
  • Metabolic abnormalities

Importantly, calcium stones do not necessarily mean that a patient is eating too much calcium.

Severely restricting normal dietary calcium can actually be counterproductive because calcium within the intestine binds oxalate and reduces its absorption.

Management

Small asymptomatic stones may sometimes simply be monitored.

When treatment is required, options include:

  • Shockwave lithotripsy (SWL)
  • Flexible ureteroscopy and laser lithotripsy
  • Percutaneous nephrolithotomy (PCNL)
  • Observation in appropriately selected patients

Prevention depends on the underlying metabolic abnormality and may include increased fluid intake, dietary modification, reduction in excessive sodium intake, potassium citrate for selected patients, thiazide therapy for hypercalciuria and treatment of hyperoxaluria or hyperuricosuria when identified.


2. Calcium Phosphate Stones

Calcium phosphate stones are less common than calcium oxalate stones.

They may contain:

  • Hydroxyapatite
  • Carbonate apatite
  • Brushite

Why do they form?

Calcium phosphate crystallisation is favoured by relatively alkaline urine.

They may be associated with:

  • Hypercalciuria
  • Renal tubular acidosis
  • Hyperparathyroidism
  • Urinary tract abnormalities
  • Certain metabolic disorders

Brushite stones deserve particular attention. They can be extremely hard and may respond poorly to shockwave treatment.

Management therefore needs to consider not only stone size and location, but also stone density and previous stone composition.


3. Uric Acid Stones

Uric acid stones behave very differently from calcium stones.

They are strongly associated with persistently acidic urine and may occur in patients with:

  • Gout
  • Metabolic syndrome
  • Diabetes
  • Obesity
  • High purine intake
  • High animal-protein intake
  • Chronic dehydration
  • Excessive uric acid production or excretion

Uric acid stones account for approximately 10% of renal stones and all uric acid stone formers are considered at increased risk of recurrence.

Why are uric acid stones special?

Because unlike most kidney stones, uric acid stones can potentially be dissolved.

Treatment involves increasing urinary pH, usually using an alkalinising medication such as potassium citrate.

For active oral dissolution therapy, urinary pH needs to be carefully monitored. Current EAU guidance describes targeting approximately pH 7.0–7.2 during chemolysis, while avoiding excessive alkalinisation because this may encourage calcium phosphate crystallisation.

This creates one of the happier conversations in stone management:

“You have a kidney stone, but we may be able to make it disappear without an operation.”

Not every uric acid stone will dissolve successfully, and obstructed or infected kidneys require separate and sometimes urgent treatment.


4. Struvite Stones: The Infection Stones

Struvite stones contain magnesium ammonium phosphate and are closely associated with urinary infections caused by certain urease-producing bacteria.

These bacteria change the chemistry of the urine, producing an alkaline environment favourable for rapid stone formation.

Struvite stones can become very large and occasionally form a branching staghorn calculus, occupying much of the kidney’s collecting system.

Why are these stones important?

The stone and infection can maintain one another.

Leaving significant infected stone material behind may therefore contribute to:

  • Recurrent urinary infection
  • Rapid stone regrowth
  • Kidney damage
  • Sepsis

Management generally involves treating the infection and achieving as complete a stone clearance as reasonably possible. Large stones frequently require PCNL, sometimes performed in more than one stage.

Infection stone formers are regarded as being at high risk of recurrence.


5. Cystine Stones

Cystine stones are uncommon and are caused by cystinuria, an inherited disorder affecting the transport of certain amino acids through the kidneys.

Cystine is relatively insoluble in urine and can crystallise to form stones.

These patients may start developing stones at a young age and can experience repeated stone episodes throughout life.

Treatment and prevention

Prevention is particularly important and may involve:

  • Very high fluid intake
  • Reduced dietary sodium
  • Urinary alkalinisation
  • Potassium citrate
  • Specialist medication such as tiopronin in selected recurrent cases

Current EAU guidance recommends aiming for a urine volume greater than 3 litres per day in adults with cystinuria and maintaining urinary pH above approximately 7.5 to improve cystine solubility.

Cystine stones are also relatively hard, which can make shockwave treatment less successful. Ureteroscopy with laser treatment or PCNL may therefore be required depending on stone burden.


6. Rare Kidney Stones

Much less commonly, stones may consist of substances such as:

  • Xanthine
  • 2,8-dihydroxyadenine
  • Ammonium urate
  • Matrix material
  • Medication-related crystalline material

These stones can sometimes provide the first clue to an underlying metabolic, genetic or medication-related disorder.

Recurrent unusual stones therefore deserve specialist investigation rather than simply repeated stone removal.


How Do Kidney Stones Present?

Some kidney stones sit quietly within the kidney and are discovered incidentally during an ultrasound or CT scan.

Others announce their arrival with considerably less subtlety.

A stone entering and obstructing the ureter may cause renal colic, producing severe pain from the loin toward the abdomen or groin.

Other symptoms can include:

  • Blood in the urine
  • Nausea and vomiting
  • Urinary urgency or frequency
  • Burning during urination
  • Recurrent urinary infection
  • Fever or chills
  • Intermittent loin discomfort

Fever plus an obstructed kidney is an emergency

An infected obstructed urinary system can progress rapidly to urosepsis.

Urgent drainage with a ureteric stent or nephrostomy tube, together with appropriate antibiotics and supportive treatment, may be required. Definitive stone treatment is generally delayed until the infection has been controlled.


How Are Kidney Stones Investigated?

CT Scan

A non-contrast CT scan of the kidneys, ureters and bladder provides detailed information regarding:

  • Stone size
  • Number of stones
  • Exact location
  • Degree of obstruction
  • Kidney anatomy
  • Stone density measured in Hounsfield units

CT density may also provide clues about stone composition and the likelihood of successful shockwave fragmentation.

Ultrasound

Ultrasound avoids radiation and is particularly useful for:

  • Surveillance
  • Detecting hydronephrosis
  • Monitoring known renal stones
  • Selected younger patients
  • Pregnancy

However, very small stones and ureteric stones can sometimes be difficult to identify accurately.

Plain X-ray

A KUB X-ray may be useful for monitoring certain radiopaque stones.

Calcium-containing stones are usually radiopaque, whereas uric acid stones are typically radiolucent on plain X-ray.


Do All Kidney Stones Need Treatment?

No.

A small, non-obstructing and asymptomatic kidney stone may sometimes be monitored with periodic imaging.

Treatment becomes more appropriate when there is:

  • Stone growth
  • Recurrent pain
  • Haematuria
  • Urinary obstruction
  • Recurrent infection
  • Declining renal function
  • Significant stone burden
  • High risk of future complications
  • Occupational or travel considerations
  • Patient preference

These factors are reflected in contemporary EAU recommendations.


Treatment Options for Kidney Stones

1. Active Surveillance

Small asymptomatic renal stones can sometimes be observed.

Follow-up may include ultrasound, X-ray or CT depending on the type, size and visibility of the stone.

The advantage is obvious: no procedure unless one becomes necessary.

The disadvantage is equally obvious: stones have not signed a contract promising to remain where they are.

They may enlarge, migrate into the ureter, cause obstruction or become symptomatic.


2. Shockwave Lithotripsy

Extracorporeal shockwave lithotripsy (SWL) uses externally generated shockwaves focused onto the stone.

The aim is to fragment the calculus into smaller pieces that can subsequently pass through the urinary tract.

Advantages

  • Non-invasive
  • Usually rapid recovery
  • No incision
  • Useful for appropriately selected renal stones

Limitations

Success depends on:

  • Stone size
  • Location
  • Density
  • Composition
  • Skin-to-stone distance
  • Renal anatomy

Hard stones such as calcium oxalate monohydrate, brushite and cystine stones may be less responsive.

More than one treatment session may be required.


3. Flexible Ureteroscopy and Laser Lithotripsy

A fine flexible telescope is passed through the urethra and bladder, up the ureter and into the kidney.

There are no external incisions.

The stone can then be fragmented or dusted using a laser, with larger fragments removed using tiny retrieval baskets.

Advantages

  • Minimally invasive
  • High stone clearance rates for appropriately selected stones
  • Can treat stones resistant to shockwave therapy
  • Allows direct visualisation
  • Suitable for many locations within the kidney

Possible disadvantages

  • Requires anaesthesia
  • Temporary ureteric stenting may be required
  • Stent discomfort
  • Bleeding or infection
  • Ureteric injury is uncommon but possible
  • Occasionally a second procedure is required

4. Percutaneous Nephrolithotomy

PCNL involves creating a small tract through the skin directly into the kidney.

It is particularly useful for:

  • Large renal calculi
  • Staghorn stones
  • Complex stones
  • Large-volume infection stones
  • Stones unlikely to respond adequately to less invasive techniques

Current EAU guidance recommends PCNL as the first-line treatment for renal stones larger than 2 cm in most suitable patients.

PCNL generally provides excellent clearance of large stone burdens but is more invasive than ureteroscopy or shockwave treatment.

Potential complications include bleeding, infection, injury to surrounding structures and the need for additional procedures.


5. Dissolution Therapy

This option is mainly relevant to uric acid stones.

Urinary alkalinisation can gradually dissolve the stone, potentially avoiding surgery.

Treatment requires:

  • Correct identification or strong suspicion of uric acid composition
  • Regular urine pH monitoring
  • Appropriate alkalinising medication
  • Follow-up imaging
  • Patient compliance

It is important not to assume that every radiolucent stone is uric acid, and treatment should be supervised appropriately.


Choosing the Right Treatment

There is no single “best” kidney stone operation.

The appropriate treatment depends on a combination of:

Stone factors

  • Size
  • Number
  • Location
  • Composition
  • Density
  • Previous growth

Kidney factors

  • Anatomy
  • Obstruction
  • Infection
  • Renal function

Patient factors

  • Symptoms
  • Medical conditions
  • Anticoagulant therapy
  • Previous stone procedures
  • Occupation
  • Travel requirements
  • Personal preference

Two patients with apparently similar 10 mm stones may therefore receive quite different recommendations.


Preventing the Next Kidney Stone

Removing a stone solves today’s problem.

Preventing another stone solves tomorrow’s problem.

Patients with recurrent stones, multiple stones, bilateral stones, unusual stone composition, young age at presentation or other high-risk features may benefit from metabolic investigation.

This may include blood testing and 24-hour urine collections assessing factors such as:

  • Urine volume
  • Calcium
  • Oxalate
  • Citrate
  • Uric acid
  • Sodium
  • Magnesium
  • Urinary pH

Stone analysis is particularly valuable whenever a stone can be retrieved. Current EAU guidance recommends reliable stone analysis and basic metabolic evaluation for stone formers, with specific metabolic assessment for high-risk patients.


General Kidney Stone Prevention

Although prevention should ultimately be tailored to stone composition, several principles apply to many stone formers.

Drink more water

Maintaining generous urine output dilutes the substances responsible for crystal formation.

Water remains wonderfully unexciting and remarkably effective.

Reduce excessive salt intake

High sodium intake can increase urinary calcium excretion and contribute to calcium stone formation.

Maintain normal dietary calcium

Patients with calcium stones should not automatically eliminate calcium-containing foods.

A balanced dietary calcium intake may actually reduce intestinal oxalate absorption.

Moderate excessive animal protein

Large amounts of meat and other purine-rich foods may contribute to increased urinary uric acid and more acidic urine in susceptible individuals.

Maintain a healthy weight

Obesity and metabolic syndrome are particularly associated with uric acid stone formation.

Investigate recurrent stones

Repeatedly removing stones without investigating why they keep forming can become a rather expensive game of geological whack-a-mole.


Can Medication Prevent Kidney Stones?

Yes, in appropriately selected patients.

Depending on the metabolic abnormality and stone composition, preventive medication may include:

  • Potassium citrate
  • Thiazide or thiazide-like medication
  • Allopurinol
  • Urinary alkalinising therapy
  • Tiopronin for selected cystinuria patients

Medication should ideally be guided by stone analysis, blood investigations and, when indicated, 24-hour urine testing rather than prescribed indiscriminately.


The Bottom Line

A kidney stone is not simply a kidney stone.

A calcium oxalate stone, uric acid stone, infection stone and cystine stone may look similar on a scan, but they can have very different causes and require very different long-term strategies.

Modern kidney stone management combines:

accurate imaging + appropriate stone removal + stone analysis + metabolic investigation + prevention.

Treatment may range from simple surveillance through to shockwave lithotripsy, flexible ureteroscopy and laser treatment, PCNL or, in selected uric acid stones, medical dissolution therapy.

The ultimate aim is not simply to leave the operating theatre stone-free.

It is to keep the patient stone-free.


When Should You See a Urologist?

Consider urological assessment if you have:

  • Recurrent kidney stones
  • Persistent loin or flank pain
  • Blood in the urine
  • Recurrent urinary infections
  • A stone associated with urinary obstruction
  • Increasing stone size on surveillance imaging
  • Multiple or bilateral kidney stones
  • A large renal calculus
  • Previous complex stone surgery

Severe pain associated with fever, chills or feeling systemically unwell requires urgent medical assessment, as an infected obstructed kidney can be a medical emergency.

This information is intended for general patient education and does not replace individual medical assessment. The appropriate investigation, surveillance and treatment of kidney stones should be tailored to the individual patient.

This blog is aligned with the current 2026 EAU Urolithiasis Guidelines, including the updated recommendations on stone composition, renal stone treatment and metabolic prevention.

EAU Guidelines on Urolithiasis

Dissolution Therapy for Uric Acid Kidney Stones: Can You Really Dissolve a Stone?

Most kidney stones need to be passed, fragmented or surgically removed. Uric acid stones are different.

Unlike calcium-based stones, a true uric acid stone can often be chemically dissolved inside the urinary tract simply by changing the acidity of the urine. This treatment is known as oral dissolution therapy, urinary alkalinisation or oral chemolysis.

For appropriately selected patients, it can mean avoiding ureteroscopy, laser treatment, shock-wave lithotripsy or percutaneous surgery altogether.

What is a uric acid stone?

Uric acid stones account for approximately 10% of urinary stones, although their frequency varies considerably between populations. They tend to develop when the urine remains persistently acidic, particularly at a urinary pH below approximately 5.5.

Risk factors include:

  • persistently acidic urine
  • low fluid intake and concentrated urine
  • high intake of animal protein and purine-rich foods
  • gout or elevated uric acid
  • obesity and metabolic syndrome
  • diabetes and insulin resistance
  • chronic diarrhoea or intestinal disease
  • high urinary uric acid excretion
  • some haematological disorders and chemotherapy

Importantly, many people who form uric acid stones do not have dramatically elevated blood or urinary uric acid. The major problem is often simply that their urine is too acidic. This is why alkalinising the urine is usually more important than immediately prescribing allopurinol.

Why can uric acid stones be dissolved?

Uric acid is poorly soluble in acidic urine. As urinary pH rises, uric acid becomes increasingly ionised and substantially more soluble.

Think of the stone as a sugar cube sitting in the wrong cup of tea. Change the chemistry of the surrounding fluid and the solid material can gradually return into solution.

The aim of dissolution therapy is therefore to raise the urinary pH sufficiently and keep it elevated throughout the day, allowing the surface of the stone to gradually dissolve.

Current European Association of Urology guidance recommends oral chemolysis using alkaline citrate or sodium bicarbonate, with urine pH generally adjusted to approximately 7.0–7.2 during active dissolution therapy.

How is dissolution therapy performed?

The most commonly used medication is potassium citrate.

Alternative alkalinising agents include:

  • sodium bicarbonate
  • sodium citrate
  • other citrate preparations

Potassium citrate is generally preferred when appropriate because sodium-containing preparations increase sodium intake and may increase urinary calcium excretion. Sodium-based treatment can nevertheless be useful when potassium therapy is unsuitable, particularly when there is concern regarding hyperkalaemia.

The exact dose needs to be individualised according to kidney function, serum electrolytes and, most importantly, the patient’s urinary pH response.

Monitoring your urine pH

This is a crucial part of treatment.

Patients are usually asked to measure their urinary pH at home using suitable pH strips or a pH meter, often at several points during the day.

The dose of alkalinising medication can then be adjusted to keep the urine within the desired range. The EAU specifically recommends teaching patients to monitor their urine pH and modify alkalinising medication accordingly.

The objective is not simply to swallow tablets. It is to achieve and maintain the correct urinary pH.

How effective is dissolution therapy?

When the stone really is composed predominantly of uric acid and urinary alkalinisation is successfully achieved, dissolution therapy can be remarkably effective.

A systematic review involving 1,075 patients reported:

Outcome Approximate rate
Complete dissolution 61.7%
Partial dissolution 19.8%
Complete or partial response 80.5%
Treatment discontinued 10.2%
Required surgical intervention 15.7%

These figures are encouraging, but they also make an important point: dissolution therapy does not work for everyone.

Success depends heavily on correct stone identification, adequate urinary alkalinisation, patient compliance and the size and burden of the stones.

How quickly will the stone disappear?

This varies considerably.

Small stones may respond relatively quickly, while larger stones can require treatment over several months. Dissolution is generally a gradual process rather than an overnight disappearing act.

One clinical series assessing stone volume found that response was associated with achieving a higher urinary pH during treatment, reinforcing the importance of adequate alkalinisation.

Follow-up imaging is therefore important to determine whether the stone is shrinking rather than simply assuming that treatment is working.

How do we know that the stone is uric acid?

This is one of the most important questions.

There is little benefit in trying to dissolve a calcium oxalate stone with urinary alkalinisation. It will remain stubbornly unimpressed.

Evidence suggesting a uric acid stone includes:

  • previous analysis confirming a uric acid stone
  • persistently acidic urinary pH
  • radiolucency on plain X-ray
  • relatively low density on non-contrast CT
  • appropriate clinical and metabolic risk factors

Dual-energy CT can sometimes help differentiate uric acid from non-uric-acid stones.

Stone composition should therefore be assessed as accurately as possible before embarking on prolonged dissolution therapy.

Advantages of dissolution therapy

The biggest advantage is obvious: it is non-invasive.

Successful treatment may avoid anaesthesia and procedures such as ureteroscopy, laser lithotripsy, shock-wave lithotripsy or PCNL.

Other potential advantages include:

  • no surgical incision
  • no instrumentation of the urinary tract
  • usually no hospital admission
  • avoidance of anaesthetic risk
  • potentially useful for patients with significant medical comorbidities
  • treatment can simultaneously address the metabolic environment responsible for future uric acid stones
  • relatively inexpensive compared with surgery
  • can potentially treat multiple uric acid stones simultaneously

For the right patient, dissolution therapy can turn a surgical problem into a metabolic one.

What are the disadvantages?

The trade-off is that dissolution therapy requires time, patience and active participation.

Patients need to take medication consistently, maintain good fluid intake, monitor urinary pH and attend follow-up investigations.

Other disadvantages include:

  • dissolution can take weeks or months
  • treatment may fail
  • the stone may only partially dissolve
  • repeated imaging may be required
  • incorrectly identified non-uric-acid stones will not dissolve
  • excessively alkaline urine can encourage formation of calcium phosphate stones
  • patients with obstruction or infection may require urgent intervention rather than simply waiting for dissolution

In the systematic review discussed above, approximately 15.7% of patients ultimately required an intervention despite attempting dissolution therapy.

Side effects of potassium citrate

Potassium citrate is generally well tolerated, but side effects can occur.

The most common are gastrointestinal and may include:

  • nausea
  • abdominal discomfort
  • bloating
  • diarrhoea
  • vomiting

Taking the medication with food may improve gastrointestinal tolerance.

A more important potential complication is hyperkalaemia, meaning an excessively high potassium concentration in the blood.

This is particularly relevant in patients with:

  • impaired kidney function
  • medications that increase potassium
  • significant cardiac disease
  • other conditions affecting potassium regulation

For this reason, kidney function and electrolytes may need monitoring during therapy.

What about sodium bicarbonate?

Sodium bicarbonate can also effectively alkalinise the urine and is an alternative when potassium citrate is unsuitable.

However, the additional sodium load can be undesirable in patients with conditions such as hypertension, fluid retention or heart failure. Sodium-containing alkali may also increase urinary calcium excretion, which is one reason potassium citrate is generally preferred when clinically appropriate.

Can the urine become too alkaline?

Yes.

More alkaline is not endlessly better.

Although increasing urinary pH improves uric acid solubility, excessive alkalinisation can increase the risk of calcium phosphate stone formation. The EAU therefore recommends targeting rather than indiscriminately increasing urinary pH.

This is why home pH monitoring is so useful.

The aim is controlled chemistry, not turning the bladder into a miniature alkaline swimming pool.

What if the stone is obstructing the kidney?

An obstructed kidney requires more caution.

If a uric acid stone is causing significant obstruction, particularly in the presence of infection, deteriorating renal function or uncontrolled symptoms, simply waiting for the stone to dissolve may be inappropriate.

An infected obstructed urinary system is a urological emergency and requires urgent drainage.

Where an obstructing uric acid stone is otherwise suitable for dissolution, urinary drainage with a ureteric stent or nephrostomy may sometimes be performed first, followed by alkalinisation. The EAU recommends oral chemolysis together with urinary drainage where uric acid stones are obstructing the collecting system.

Does allopurinol dissolve uric acid stones?

Not directly in the same way that alkalinisation does.

Allopurinol reduces the production of uric acid and is particularly useful in patients with hyperuricosuria, gout or continued uric acid stone formation despite appropriate management.

However, most uric acid stone formers have excessively acidic urine as the dominant problem. The AUA therefore recommends potassium citrate as first-line therapy for urinary alkalinisation rather than routinely using allopurinol as first-line treatment for every patient with uric acid stones.

Allopurinol may be added when there is significant hyperuricosuria or recurrent stone formation despite appropriate urinary alkalinisation. The EAU similarly recommends allopurinol for hyperuricosuric urate stone formers.

Preventing the stone from coming back

Dissolving the existing stone is only half the job.

Uric acid stone formers are considered at high risk of recurrence, so the underlying metabolic environment should also be addressed.

Long-term prevention may include maintaining a generous fluid intake, moderating excessive animal protein and purine intake, weight and metabolic health management, continued urinary alkalinisation when indicated, and treatment of hyperuricosuria where appropriate.

A metabolic stone assessment, often including blood tests and 24-hour urine collections, can help identify the factors driving recurrent stone formation.

Dissolution therapy versus surgery

There is no universal winner.

Dissolution therapy is particularly attractive when:

  • the stone is highly likely to be uric acid
  • symptoms are controlled
  • there is no untreated infection
  • renal function is satisfactory
  • immediate stone clearance is unnecessary
  • the patient can reliably monitor urinary pH and attend follow-up

Surgical treatment may be preferable when:

  • the diagnosis of uric acid stone is uncertain
  • the stone is causing significant or persistent obstruction
  • infection is present
  • pain is difficult to control
  • rapid stone clearance is required
  • the stone fails to shrink despite adequate alkalinisation
  • the patient prefers definitive treatment

The bottom line

Uric acid stones have one rather convenient weakness: their chemistry can be used against them.

By raising urinary pH with medications such as potassium citrate, genuine uric acid calculi can often be progressively dissolved without an operation. Published evidence suggests that approximately 80% of appropriately treated patients achieve at least partial dissolution, although complete dissolution occurs in a smaller proportion and some patients will ultimately require surgery.

Successful treatment depends on three things: correctly identifying the stone, achieving the appropriate urinary pH, and monitoring the response.

For selected patients, dissolution therapy offers something unusual in stone surgery: rather than breaking the stone, extracting it or blasting it with a laser, we may simply persuade it to disappear.

This information is intended for general patient education and does not replace individual assessment by a urologist. Treatment and urinary pH targets should be individualised, particularly in patients with renal impairment, infection, obstruction or electrolyte abnormalities.

Kidney Stones: Symptoms, Causes and Treatment Options Explained

Kidney stones: symptoms, treatment and prevention

Kidney stones can cause sudden, intense pain, but some are discovered by chance and cause no symptoms. The right treatment depends on where a stone sits, its size, whether urine can drain, whether infection is present and how well the kidneys are working. If you have suspected stone pain, an assessment can establish which approach is safest for you.

What is a kidney stone?

A kidney stone forms when substances in urine crystallise and grow. Calcium-based stones are common; other types include uric acid, infection-related (struvite) and cystine stones. A stone may remain in the kidney or move into the ureter, the tube carrying urine to the bladder. A ureteric stone can obstruct urine flow and cause renal colic.

Symptoms to recognise

  • Severe pain in the side or back that may travel towards the lower abdomen or groin, often in waves
  • Blood in the urine, which may be visible or detected on a test
  • Nausea or vomiting
  • Urgency, frequent urination or discomfort passing urine, particularly when a stone is near the bladder

Cloudy urine, fever or chills may indicate infection. These symptoms also have other possible causes, so imaging and tests are important.

Seek urgent care at an emergency department if you have fever or chills with suspected stone pain, cannot pass urine, cannot keep fluids down, have pain that cannot be controlled, or have a single functioning kidney or known kidney disease with possible obstruction. An infected, obstructed kidney is a urological emergency: antibiotics and urgent drainage with a ureteric stent or nephrostomy may be needed before definitive stone treatment.

Why do stones form?

Low fluid intake, heavy sweating, a high-salt diet, previous stones and family history can increase risk. Other contributors include certain medicines and conditions such as gout, bowel disease or recurrent infection. The causes differ by stone type. Finding the type matters when planning prevention.

How are kidney stones diagnosed?

Assessment usually includes your symptoms and medical history, urine testing for blood and infection, and blood tests to check kidney function when appropriate. A low-dose CT scan without contrast is often used for adults with suspected renal colic because it shows the size and position of a stone and signs of obstruction. Ultrasound may be preferred first in pregnancy and some other circumstances. If you pass or have a stone removed, laboratory analysis can guide future prevention.

What are the treatment options?

Observation and pain relief. Many small ureteric stones pass without a procedure. This is reasonable when pain is controlled, there is no infection or concerning obstruction, and kidney function is safe. Your clinician will arrange follow-up to confirm that the stone has passed or the obstruction has resolved. Pain relief is tailored to your health; anti-inflammatory medicines may be useful but are unsuitable for some people, including those with impaired kidney function. Drink normally and avoid dehydration; forcing large amounts of water during acute colic does not push a blocked stone through.

Medication to help passage. An alpha blocker may improve passage for selected stones in the lower ureter, especially those around 5–10 mm. This use is off-label and should be discussed alongside possible adverse effects, such as dizziness. It is not suitable as a substitute for urgent treatment if infection, uncontrolled pain or worsening kidney function develops.

Shock wave lithotripsy (SWL or ESWL). Shock waves delivered from outside the body break a suitable stone into fragments. Its success depends on factors including stone size, position and density; further treatment can sometimes be needed.

Ureteroscopy and laser treatment. A fine telescope passes through the urethra and bladder into the ureter or kidney. The stone can be removed or fragmented with a laser. A temporary ureteric stent is sometimes placed and can cause urinary discomfort until removal.

Percutaneous nephrolithotomy (PCNL). For some large or complex kidney stones, instruments are passed through a small opening in the back to remove the stone. This is more invasive than ureteroscopy or shock wave treatment and has its own bleeding and infection risks.

Your urologist will discuss the expected chance of clearing the stone, anaesthetic needs, recovery, possible stenting and risks of each appropriate option.

Reducing the chance of another stone

For most people, drinking enough fluid to keep urine dilute is a useful starting point, particularly in Queensland heat. If you have heart failure or kidney disease, follow your treating team’s fluid advice instead of increasing intake on your own. Reduce excess salt, maintain a balanced diet and avoid unnecessarily restricting normal dietary calcium. Further dietary advice or preventive medication should be based on the stone’s composition and, for recurrent or higher-risk stones, blood and 24-hour urine testing. Follow-up imaging may be recommended to check for residual or new stones.

When should you see a urologist in Brisbane?

Arrange an assessment if you have a diagnosed stone that has not passed, recurrent stones, persistent pain, blood in the urine, or concerns about kidney function. If you are acutely unwell or have fever with stone symptoms, go to an emergency department rather than waiting for a routine appointment.

This article is general information and does not replace individual medical advice.

References

  1. European Association of Urology. EAU Guidelines on Urolithiasis (2026).
  2. National Institute for Health and Care Excellence. Renal and ureteric stones: assessment and management (NG118).
  3. Healthdirect Australia. Kidney stones: symptoms, diagnosis and treatment.
  4. Kidney Health Australia. Kidney stones.